During the past decade, Medical Oncology Associates conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 25 clinical trials were completed, i.e. on average, 86.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 17 clinical trials were completed. i.e. 170% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology Associates" #1 sponsor was "Celgene" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Associates" #1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Associates" are "Breast Cancer" (5 trials), "Multiple Myeloma" (3 trials), "Pancreatic Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Chemotherapy-induced Thrombocytopenia" (2 trials). Many other conditions were trialed in "Medical Oncology Associates" in a lesser frequency.

Most popular intervention types in "Medical Oncology Associates" are "Drug" (40 trials), "Biological" (10 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Bevacizumab" (5 trials), "Carboplatin" (5 trials), "Paclitaxel" (4 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Associates" are 43 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology Associates". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Medical Oncology Associates, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Associates, 11 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".